Ventyx Biosciences, Inc. financial data

Symbol
VTYX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.86K % +10.8%
Debt-to-equity 9.6 % -2.74%
Return On Equity -48.1 % +12.4%
Return On Assets -43.9 % +12.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.4M shares +0.92%
Common Stock, Shares, Outstanding 71.3M shares +0.95%
Entity Public Float 142M USD -89.1%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 71.3M shares +0.9%
Weighted Average Number of Shares Outstanding, Diluted 71.3M shares +0.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 87.7M USD -34.7%
General and Administrative Expense 29M USD -9.78%
Operating Income (Loss) -117M USD +29.8%
Nonoperating Income (Expense) 10.1M USD -27%
Net Income (Loss) Attributable to Parent -107M USD +30.1%
Earnings Per Share, Basic -1 USD/shares +40.2%
Earnings Per Share, Diluted -1 USD/shares +40.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32M USD -48.2%
Marketable Securities, Current 161M USD -24.6%
Cash, Cash Equivalents, and Short-term Investments 253M USD +0.28%
Assets, Current 201M USD -30.5%
Property, Plant and Equipment, Net 501K USD -28.7%
Operating Lease, Right-of-Use Asset 8.88M USD -10.4%
Other Assets, Noncurrent 12K USD -87.5%
Assets 211M USD -29.8%
Accounts Payable, Current 993K USD -56.6%
Employee-related Liabilities, Current 4.72M USD +7.06%
Accrued Liabilities, Current 9.08M USD +0.87%
Liabilities, Current 11.3M USD -8.49%
Operating Lease, Liability, Noncurrent 8.84M USD -11.8%
Liabilities 20.1M USD -9.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax 223K USD -74.5%
Retained Earnings (Accumulated Deficit) -632M USD -20.3%
Stockholders' Equity Attributable to Parent 191M USD -31.4%
Liabilities and Equity 211M USD -29.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.7M USD +46%
Net Cash Provided by (Used in) Financing Activities 96.2M USD +97.7%
Net Cash Provided by (Used in) Investing Activities 26.4M USD -36.8%
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 71.3M shares +0.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 816K USD -99.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.9M USD -47.5%
Deferred Tax Assets, Valuation Allowance 130M USD +32.8%
Deferred Tax Assets, Gross 132M USD +31.6%
Operating Lease, Liability 10M USD -9.17%
Depreciation 296K USD 0%
Payments to Acquire Property, Plant, and Equipment 16K USD -90.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107M USD +29%
Lessee, Operating Lease, Liability, to be Paid 13.3M USD -13.4%
Property, Plant and Equipment, Gross 1.11M USD -0.81%
Operating Lease, Liability, Current 1.18M USD +16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.2M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.14M USD +2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.26M USD -24.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.27M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 76.8M USD +45.4%
Unrecognized Tax Benefits 2.25M USD +20.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.33M USD +3%
Operating Lease, Payments 500K USD +25%
Additional Paid in Capital 823M USD +2.47%
Deferred Tax Assets, Net of Valuation Allowance 2.11M USD -15.1%
Share-based Payment Arrangement, Expense 19.4M USD -19%